| Literature DB >> 27347515 |
Leslie L McKnight1, Anna K Shoveller2, Secundino Lopez3, James France1.
Abstract
A new two-pool model to describe glucose kinetics in the steady state is presented. The pools are plasma glucose, Q 1, and tissue glucose, Q 2 (both µmol). The flows (all µmol/min) into the plasma pool (Pool 1) are absorbed glucose entry from dietary sources, labelled glucose infusion, and hepatic glucose production. There is one flow out of Pool 1, glucose uptake by the tissues. Inflows to the tissues pool (Pool 2) are from plasma and glycogenolysis. Outflows from Pool 2 are to plasma, glucose oxidation, and glycogenesis and other metabolism. Application of the model was illustrated using experimental data derived from healthy adult Labrador Retrievers in the fasted and fed (repeated meal feeding) states. In general, model derived estimates of glucose kinetics were representative of normal glucose metabolism, where rates of glucose production and uptake are similar and act to maintain blood glucose concentrations. Furthermore, estimates of within tissue glucose cycling indicated glycogenolysis in fasting and glycogenesis when fed. In the fasted state, model outputs were consistent with those reported in the canine literature derived using a single pool model.Entities:
Year: 2015 PMID: 27347515 PMCID: PMC4897039 DOI: 10.1155/2015/286076
Source DB: PubMed Journal: Int Sch Res Notices ISSN: 2356-7872
Figure 1Two-pool model for describing glucose kinetics (a) and the kinetic scheme for labeled glucose (b). The first pool represents total (labelled plus unlabelled) glucose in plasma, and second represents total glucose in tissues. Arrowed solid lines show flows, hollow arrow shows glucose application (infusion), a solid dot indicates a flow active only in the fasted state, a hollow dot indicates a flow active only in the fed state, and the broken line represents sampling. V represents the volume of pool i, Q and q represent the quantity of total and labelled glucose in pool i, respectively, and F and f represent the flow of total and labelled glucose to pool i from pool j, respectively.
Key experimental details.
| Item | Experiment A [ | Experiment B |
|---|---|---|
| Study design | Design: parallel crossover | Design: parallel crossover |
|
| ||
| Study population | A total of 6 neutered male Labrador Retrievers, 3-black-coated (3.9 yr; 27.3 kg) and 3-chocolate-coated (6.8 yr; 35.0 kg) | A total of 12 black Labrador Retrievers, 5 spayed females and 7 neutered males (27.0 ± 0.6 kg; 4.9 ± 0.2 yr of age) |
|
| ||
| Key details of glucose kinetics experiment | Isotope: U-13C-glucose | Isotope: U-13C-glucose |
Isotope was delivered by primed constant intravenous infusion, blood samples were collected by jugular venipuncture, and breath was collected via indirect calorimetry.
Glucose kinetics parameters in fasted adult Labrador Retrievers fed two different diets (control, CON, or treatment, TRMT). Data are expressed as mean and standard error (flows are expressed as μmol/(min·kg)).
| Diet | BW, kg |
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| Experiment A | |||||||||
| CON | 30.9 ± 1.6 | 0.136 | 0.021 ± 0.001 | 0.003 ± 0.000 | 2.8 ± 0.2 | 0 | 6.5 ± 0.3 | 6.9 ± 0.3 | −2.5 ± 0.2 |
| TRMT | 31.3 ± 1.8 | 0.136 | 0.019 ± 0.001 | 0.002 ± 0.000 | 2.8 ± 0.5 | 0 | 7.3 ± 0.6 | 7.7 ± 0.6 | −2.6 ± 0.5 |
| CON† | 30.9 ± 1.6 | 0.136 | 0.010 ± 0.002 | 0.005 ± 0.001 | 2.1 ± 0.2 | 0 | 19.2 ± 4.9 | 20.0 ± 5.1 | −1.9 ± 0.2 |
| TRMT† | 31.3 ± 1.8 | 0.136 | 0.011 ± 0.002 | 0.006 ± 0.001 | 2.4 ± 0.1 | 0 | 14.4 ± 3.4 | 15.0 ± 3.5 | −2.2 ± 0.1 |
| Experiment B | |||||||||
| CON | 27.4 ± 0.7 | 0.136 | 0.007 ± 0.000 | 0.001 ± 0.000 | 3.9 ± 0.4 | 0 | 19.7 ± 1.0 | 19.9 ± 1.2 | −3.7 ± 0.5 |
| TRMT | 27.6 ± 0.7 | 0.136 | 0.007 ± 0.000 | 0.001 ± 0.000 | 4.0 ± 0.3 | 0 | 19.8 ± 1.2 | 19.7 ± 0.9 | −3.5 ± 0.4 |
Measured enrichment values (last sampling time point).
†Extrapolated steady state enrichments.
Postprandial glucose kinetics parameters in adult Labrador Retrievers fed two different diets (control, CON, or treatment, TRMT). Data are expressed as mean and standard error (flows are expressed as μmol/(min·kg)).
| Diet | BW, kg |
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Experiment A | ||||||||||
| CON† | 30.9 ± 1.6 | 0.136 | 0.004 ± 0.000 | 0.001 ± 0.000 | 12.5 ± 0.3 | 34 ± 5 | 0 | 35.0 ± 4.7 | 22 ± 4 | 16.3 ± 2.2 |
| TRMT† | 31.3 ± 1.8 | 0.136 | 0.005 ± 0.000 | 0.001 ± 0.000 | 10.1 ± 1.1 | 29 ± 2 | 0 | 30.5 ± 2.0 | 20 ± 1 | 14.1 ± 1.0 |
| CON‡ | 30.9 ± 1.6 | 0.136 | 0.003 ± 0.001 | 0.002 ± 0.001 | 6.4 ± 0.6 | 78 ± 34 | 0 | 80.6 ± 34.9 | 72 ± 33 | 37.5 ± 16.3 |
| TRMT‡ | 31.3 ± 1.8 | 0.136 | 0.003 ± 0.001 | 0.003 ± 0.000 | 5.7 ± 0.4 | 48 ± 10 | 0 | 49.3 ± 10.6 | 42 ± 10 | 22.9 ± 5.0 |
| Experiment B§ | ||||||||||
| CON | 27.4 ± 0.7 | 0.136 | 0.001 ± 0.000 | 0.001 ± 0.000 | 61 ± 18 | 224 ± 56 | 0 | 225 ± 56 | 163 ± 40 | 35.6 ± 7.1 |
| TRMT | 27.6 ± 0.7 | 0.136 | 0.001 ± 0.000 | 0.001 ± 0.000 | 37 ± 7 | 152 ± 30 | 0 | 153 ± 30 | 116 ± 23 | 35.2 ± 5.7 |
Dogs were fed 14 g/meal glucose.
†Experimental enrichment values (last sampling time point).
‡Extrapolated steady state enrichments.
§Dogs were fed 23 g/meal glucose.
¶Crude estimate of glucose absorption, based on diets providing 760 g glucose/kg fed in 25 min intervals.
Analysis of measurement errors in infusion rate (I) and plasma enrichment (e 1) on model solutions.
| Item |
|
|
|
|
|
|---|---|---|---|---|---|
| Fasted | |||||
| Slope, (Δ | — | — | 0.157 ± 0.036 | 0.160 ± 0.035 | 0.001 ± 0.006 |
| Error, % | — | — | 1.2 | 1.2 | 0.0 |
| Slope (Δ | −0.062 ± 0.022 | — | −0.164 ± 0.037 | −0.165 ± 0.036 | 0.058 ± 0.027 |
| Error, % | 3.3 | 1.2 | 1.2 | 3.6 | |
| Postprandial | |||||
| Slope (Δ | — | 0.873 ± 0.350 | — | 0.874 ± 0.350 | 0.874 ± 0.277 |
| Error, % | — | 1.0 | — | 1.0 | 1.3 |
| Slope (Δ | −0.303 ± 0.090 | −0.905 ± 0.357 | — | −0.905 ± 0.357 | −0.602 ± 0.295 |
| Error, % | 1.0 | 1.0 | — | 1.0 | 1.0 |
I and e 1 were perturbed in turn by 0, ±10, and ±20%.
Plasma glucose rate of appearance (R , μmol/(min·kg)) and glucose oxidation (Ox, μmol/(min·kg)) reported in the canine literature (data means are presented).
| Reference | Experimental groups (conditions) | BW, kg |
| Ox |
|---|---|---|---|---|
| [ | 2-3H [basal | 21.1 | 22; 40.1 | — |
| 3-3H [basal; methylprednisolone] | 21.1 | 14.4; 18.4 | — | |
| U-14C [basal; methylprednisolone] | 21.1 | 14.4; 19.3 | — | |
|
| ||||
| [ | Healthy; obese | 12.2; 17.5 | 15.6; 13.9 | — |
|
| ||||
| [ | Clamped euglycemia [0; 7; 40; 120 mU/kg/h constant insulin infusion] | 22 | 19.1; 17.9; 54.7; 101.7 | — |
| Clamped hyperglycemia [0; 7; 40; 120 mU/kg/h constant insulin infusion] | 22 | 36; 46.1; 96.1; 167.8 | — | |
|
| ||||
| [ | Healthy [saline; AICAR†; methypalmoxirate; AICAR and methypalmoxirate] | 20.1 | 13; 17.5; 14.5; 16 | — |
| Diabetic [saline; AICAR; methypalmoxirate; AICAR and methypalmoxirate] | 20.1 | 32.4; 31.6; 23.6; 21.9 | — | |
|
| ||||
| [ | Saline infusion; pulsatile; constant octanoate infusion | — | 16.7; 18.3; 14.4 | — |
|
| ||||
| [ | Baseline; 6 wk; 12 wk moderate-fat feeding | 27.5; —; 29 | 14.4; 18.3; 18.3 | — |
|
| ||||
| [ | Saline; nicotinic acid | — | 15; 24 | 6; 14 |
|
| ||||
| [ | Basal | 20.4 | 12.7 | — |
|
| ||||
| [ | Basal [U-14C; 3-3H] | 15.2 | 8.7; 13.9 | — |
|
| ||||
| [ | Basal | — | 24.3 | — |
|
| ||||
| [ | Basal [saline; high FFA‡; low FFA infusion] | — | 15.3; 15.3; 15.3 | 5; 4.8; 8.9 |
| Epinephrine infusion [saline; high FFA; low FFA infusion] | — | 15; 15.8; 15.3 | 4.9; 5.2; 9.7 | |
| Propranolol and phentolamine infusion [saline; high FFA; low FFA infusion] | — | 15.2; 15.0; 15.2 | 5.1; 5.1; 9.8 | |
|
| ||||
| Overall mean and SE | 20.9 ± 0.6 | 26.8 ± 4.3 | 7.1 ± 0.9 | |
Basal refers to fasted rest.
†AICAR: 5-aminoimidazole-4-carboxamide ribonucleotide.
‡FFA: free fatty acids.